Genome Editing/Genome Engineering Market Size, Share & Trends Analysis Report By Technology (CRISPR, TALEN, ZFN, Antisense, and Other Technologies), By Products, By Application, By End Users, Region And Segment Forecasts, 2023-2031.

Report Id: 1174 Pages: 180 Last Updated: 20 March 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Genome Editing/Genome Engineering Market Segmentation:

Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Technology

  • CRISPR
  • TALEN
  • ZFN
  • Antisense
  • Other Technologies

Genome Editing/Genome Engineering Market

Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on Products

  • Reagents & Consumables
  • Software & Systems
  • Services

Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on Application

  • Animal Genetic Engineering
  • Plant Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery & Development
  • Other

Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on End Users

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Government Research Institutes

Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on Region

Europe Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country

  • U.S.
  • Canada

Asia Pacific Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Genome Editing/Genome Engineering Market Snapshot

Chapter 4. Global Genome Editing/Genome Engineering Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Major Investment, Partnerships and Collaborations in Genomics Research

Chapter 5. Market Segmentation 1: By Technology Estimates & Trend Analysis

5.1. By Technology & Market Share, 2020 & 2028

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following By Technology:

5.2.1. CRISPR

5.2.2. TALEN

5.2.3. ZFN

5.2.4. Antisense

5.2.5. Other Technologies

Chapter 6. Market Segmentation 2: Product Estimates & Trend Analysis

6.1. Product Type & Market Share, 2020 & 2028

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Product Type:

6.2.1. Reagents & Consumables

6.2.2. Software & Systems

6.2.3. Services

Chapter 7. Market Segmentation 3: Application Estimates & Trend Analysis

7.1. Application Type & Market Share, 2020& 2028

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Application Type:

7.2.1. Animal Genetic Engineering

7.2.2. Plant Genetic Engineering

7.2.3. Diagnostic Applications

7.2.4. Drug Discovery & Development

7.2.5. Other

Chapter 8. Market Segmentation 4: End-Users Estimates & Trend Analysis

8.1. End-Users & Market Share, 2020 & 2028

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:

8.2.1. Pharmaceutical Companies

8.2.2. Biotechnology Companies

8.2.3. Academic & Government Research Institutes

Chapter 9. Genome Editing/Genome Engineering Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by By Technology, 2020-2028

9.1.2. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by Product, 2020-2028

9.1.3. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by Application, 2020-2028

9.1.4. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by End-Users, 2020-2028

9.1.5. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by country, 2020-2028

9.2. Europe

9.2.1. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, 2020-2028

9.2.2. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, 2020-2028

9.2.3. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, 2020-2028

9.2.4. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by End-Users, 2020-2028

9.2.5. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by country, 2020-2028

9.3. Asia Pacific

9.3.1. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, 2020-2028

9.3.2. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, 2020-2028

9.3.3. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, 2020-2028

9.3.4. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by End-Users, 2020-2028

9.3.5. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by country, 2020-2028

9.4. Latin America

9.4.1. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, (US$ Million)

9.4.2. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, (US$ Million)

9.4.3. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, (US$ Million)

9.4.4. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by country, (US$ Million) 2020-2028

9.5. Middle East & Africa

9.5.1. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, (US$ Million)

9.5.2. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, (US$ Million)

9.5.3. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, (US$ Million)

9.5.4. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by country, (US$ Million) 2020-2028 

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Thermo Fisher Scientific Inc.

10.2.2. Merck & Co. Inc

10.2.3. Horizon Discovery group plc

10.2.4. Genscript biotech corporation

10.2.5. Sangamo Therapeutics Inc.

10.2.6. lonza group ltd

10.2.7. Editas Medicine Inc

10.2.8. Crispr Therapeutics

10.2.9. Eurofins Scientific Inc

10.2.10. Precision Biosciences Inc

10.2.11. Oxford Genetics Ltd.

10.2.12. Intellia Therapeutics Inc

10.2.13. Synthego corporation

10.2.14. Vigene Biosciences Inc

10.2.15. Epigenie

10.2.16. Integrated DNA Technologies Inc

10.2.17. New England Biolabs Inc

10.2.18. Origene Technologies Inc

10.2.19. Transposagen Biopharmaceuticals Inc

10.2.20. Creative Biogene Inc

10.2.21. Other Prominent Player

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
2775
Security Code field cannot be blank!

Frequently Asked Questions

The Genome Editing/Genome Engineering Market Size is valued at 5900.0 Million in 2022 and is predicted to reach 28469.3 Million by the year 2031.

The Genome Editing/Genome Engineering Market is expected to grow at a 19.20 % CAGR during the forecast period for 2023-2031.

Thermo Fisher Scientific Inc., Merck & Co. Inc, Horizon Discovery group plc, Genscript biotech corporation, Sangamo Therapeutics Inc., lonza group ltd

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying